Not applicableStudy completedNCT02200887What this trial is testingSleep Homeostasis in Parkinson's DiseaseWho this might be right forParkinson Disease Salvatore Galati 48
Large-scale testing (Phase 3)Ended earlyNCT05116813What this trial is testingOpen-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based TherapyWho this might be right forParkinson DiseaseDyskinesia, Drug-InducedDyskinesias Addex Pharma S.A. 17
Not applicableUnknownNCT05795088What this trial is testingContinuous Theta Burst Stimulation as Potential Biomarker of Levodopa-induced Dyskinesias in Parkinson's DiseaseWho this might be right forParkinson Disease Fondazione Policlinico Universitario Agostino Gemelli IRCCS 60
Testing effectiveness (Phase 2)Study completedNCT01385592What this trial is testingEvaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced DyskinesiasWho this might be right forDyskinesiasParkinson DiseaseMovement Disorders+1 more Novartis Pharmaceuticals 78
Testing effectiveness (Phase 2)Study completedNCT01336088What this trial is testingADX48621 for the Treatment of Levodopa Induced Dyskinesia in Patients With Parkinson's DiseaseWho this might be right forParkinson's Disease Addex Pharma S.A. 83
Testing effectiveness (Phase 2)Study completedNCT04435431What this trial is testingA Clinical Study of Mesdopetam in Patients With Parkinson's Disease Experiencing Levodopa Induced DyskinesiaWho this might be right forParkinson Disease Integrative Research Laboratories AB 155
Early research (Phase 1)Study completedNCT01023282What this trial is testingSafety and Tolerability Study Evaluating ACR325 in Parkinson's Disease PatientsWho this might be right forParkinson's DiseaseTolerability NeuroSearch A/S 22
Early research (Phase 1)UnknownNCT06021756What this trial is testingPhase I Open-label Study of Low-dose Ketamine Infusion Treatment in Levodopa-Induced Dyskinesia in Parkinson's DiseaseWho this might be right forLevodopa-Induced DyskinesiaParkinson's Disease University of Arizona 9
Early research (Phase 1)Study completedNCT02003248What this trial is testingA Feasibility Study to Evaluate Safety and Initial Effectiveness of ExAblate Transcranial MR Guided Focused Ultrasound for Unilateral Pallidotomy in the Treatment of Dyskinesia of Parkinson's DiseaseWho this might be right forLevodopa Induced Dyskinesia in Patients With Parkinson's Disease Yonsei University 10
Testing effectiveness (Phase 2)Study completedNCT05766813What this trial is testingLenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's DiseaseWho this might be right forParkinson Disease Intra-Cellular Therapies, Inc. 79
Testing effectiveness (Phase 2)Study completedNCT01173731What this trial is testingOpen Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced DyskinesiasWho this might be right forParkinson DiseaseDyskinesia, Drug-InducedLevodopa Novartis Pharmaceuticals 66
Testing effectiveness (Phase 2)Study completedNCT01491932What this trial is testingOpen-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced DyskinesiasWho this might be right forDyskinesiasParkinson DiseaseMovement Disorders+2 more Novartis Pharmaceuticals 129
Testing effectiveness (Phase 2)Study completedNCT00986414What this trial is testingEvaluation of the Efficacy and Safety of AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's DiseaseWho this might be right forParkinson DiseaseDyskinesias Novartis 260